Waste management, COVID-19 and occupational safety and health: Challenges, insights and evidence.

Different fields of knowledge have faced challenges due to the COVID-19 pandemic. Essential public services serving the population's needs were maintained. Previous studies have addressed the possibility of health hazards from handling solid waste (SW) among trash collection service workers, without introducing any data proving or dismissing those risks. Occupational health is stated in at least 2 of the 17 Sustainable Development Goals. Pearson Coefficient (r) was employed to analyze the correlation between the number of cases of COVID-19 in SW collection workers in the city of São Paulo, considering the district city halls where the COVID-19 patients live and the SW collection workers' route, from March 2020 to March 2021. Employees who collected wastes with COVID-19: 2% collected healthcare SD, 4% worked at the waste transshipment stations, 10% household variable route collection, and 83% in defined routes collecting household wastes. Positive and moderate correlation was confirmed (r = 0.59) between the total number of COVID-19 cases and the trash collection routes, and the number of contaminated COVID-19 workers from their trash collection routes. Considering concessionary companies separately, the correlation found in the Southeastern grouping is 0.77 (positive and high correlation), and the correlation found in the Northwestern grouping is 0.18 (positive but insignificant correlation). The Northwestern grouping's concessionary had implemented more effective occupational health and safety management policies and disclosed them among their stakeholders. Results suggest concern related to occupational health and safety for SW collection workers and substantiating the vulnerability of this essential activity during the pandemic.

Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19.

The distribution of oral rabies vaccine baits containing replication-competent live viruses poses certain environmental safety risks; among others, the possibility of reversion to or an increase in virulence. Hence, the genetic stability of the complete genome of the most widely used oral rabies vaccine virus, SAD B19, was examined after four and 10 serial i.c. passages in foxes and mice, respectively. It was shown that the consensus strain of SAD B19 was extremely stable in vivo. After 10 consecutive passages in mice not a single mutation was observed. In foxes, seven single nucleotide exchanges were found between the first and fourth passage, of which only one resulted in an amino acid exchange at position 9240 of the L-gene. This mutation was not observed during the first three passages and, furthermore, it was shown that this mutation was not linked to enhanced virulence.

Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife.

The elimination of rabies from the red fox (Vulpes vulpes) in Western Europe has been achieved by the oral rabies vaccination (ORV) of wildlife with a range of attenuated rabies virus strains. With the exception of the vaccinia rabies glycoprotein recombinant vaccine (VRG), all strains were originally derived from a common ancestor; the Street Alabama Dufferin (SAD) field strain. However, after more than 30 years of ORV it is still not possible to distinguish these vaccine strains and there is little information on the genetic basis for their attenuation. We therefore sequenced and compared the full-length genome of five commercially available SAD vaccine viruses (SAD B19, SAD P5/88, SAG2, SAD VA1 and SAD Bern) and four other SAD strains (the original SAD Bern, SAD VA1, ERA and SAD 1-3670 Wistar). Nucleotide sequencing allowed identifying each vaccine strain unambiguously. Phylogenetic analysis revealed that the majority of the currently used commercial attenuated rabies virus vaccines appear to be derived from SAD B19 rather than from SAD Bern. One commercially available vaccine virus did not contain the SAD strain mentioned in the product information of the producer. Two SAD vaccine strains appeared to consist of mixed genomic sequences. Furthermore, in-del events targeting A-rich sequences (in positive strand) within the 3' non-coding regions of M and G genes were observed in SAD-derivates developed in Europe. Our data also supports the idea of a possible recombination that had occurred during the derivation of the European branch of SAD viruses. If confirmed, this recombination event would be the first one reported among RABV vaccine strains.